BACKGROUND: Hospitalization rates, morbidity and mortality are undesirably high in heart failure (HF) patients. An organized system of HF specialist outpatient care has been recommended, but the best way to implement such programmes is not clearly established. AIM: To evaluate HF patient characteristics, management and outcome in outpatient HF clinics. METHODS: Data from HF patients at 24 hospital outpatient clinics were entered in a common database allowing each centre to monitor its own practice against the rest. RESULTS: A total of 3632 patients were included. At the last registered visit, ACE inhibitors or angiotensin receptor blockers were prescribed for 87%; beta blockers, 83%; spironolactone, 33% and loop diuretics 87% of the patients. The number of hospital admissions and days stayed in hospital for cardiovascular reasons were significantly reduced (p<0.001). Mortality was high, 11.5 and 22% after one and two years, respectively. CONCLUSIONS: The use of evidence-based medication increased over time in HF clinics with the ability of the individual clinics to compare their treatment to other sites. Thus, establishment of specialized HF clinics managed in a registry network might improve the quality of care.
BACKGROUND: Hospitalization rates, morbidity and mortality are undesirably high in heart failure (HF) patients. An organized system of HF specialist outpatient care has been recommended, but the best way to implement such programmes is not clearly established. AIM: To evaluate HF patient characteristics, management and outcome in outpatient HF clinics. METHODS: Data from HF patients at 24 hospital outpatient clinics were entered in a common database allowing each centre to monitor its own practice against the rest. RESULTS: A total of 3632 patients were included. At the last registered visit, ACE inhibitors or angiotensin receptor blockers were prescribed for 87%; beta blockers, 83%; spironolactone, 33% and loop diuretics 87% of the patients. The number of hospital admissions and days stayed in hospital for cardiovascular reasons were significantly reduced (p<0.001). Mortality was high, 11.5 and 22% after one and two years, respectively. CONCLUSIONS: The use of evidence-based medication increased over time in HF clinics with the ability of the individual clinics to compare their treatment to other sites. Thus, establishment of specialized HF clinics managed in a registry network might improve the quality of care.
Authors: Thomas T H Wan; Amanda Terry; Enesha Cobb; Bobbie McKee; Rebecca Tregerman; Sara D S Barbaro Journal: Health Serv Res Manag Epidemiol Date: 2017-04-18
Authors: Jozine M Ter Maaten; Pieter Martens; Kevin Damman; Kenneth Dickstein; Piotr Ponikowski; Chim C Lang; Leong L Ng; Stefan D Anker; Nilesh J Samani; Gerasimos Filippatos; John G Cleland; Faiez Zannad; Hans L Hillege; Dirk J van Veldhuisen; Marco Metra; Adriaan A Voors; Wilfried Mullens Journal: Clin Res Cardiol Date: 2020-01-30 Impact factor: 5.460
Authors: Nicholas R Jones; Andrea K Roalfe; Ibiye Adoki; F D Richard Hobbs; Clare J Taylor Journal: Eur J Heart Fail Date: 2019-09-16 Impact factor: 15.534